CL

Business profile & competitive position

Colgate-Palmolive Company is classified in the Consumer Defensive sector and the Household & Personal Products industry. It operates two main segments: Oral, Personal and Home Care (toothpaste, toothbrushes, soaps, deodorants, skin-health products, household cleaners and fabric conditioners) and Hill’s Pet Nutrition (specialty dog and cat foods). The company sells into more than 200 countries and territories through retailers, wholesalers, eCommerce platforms, veterinarians and certain direct-to-consumer channels.

The business model is built on repeat-purchase, everyday-use brands supported by a global manufacturing and distribution footprint. In 2025, Oral Care contributed 44% of worldwide net sales, Personal Care 17%, Home Care 16% and Pet Nutrition 23%. That mix points to a portfolio anchored in low-discretion categories: consumers tend to keep brushing, washing and feeding pets even when budgets tighten. At the same time, the reported net margin of 9.7% is solid but not unusually high for a staples manufacturer; profitability comes from volume, pricing power and cost discipline rather than extraordinary per-unit margins.

The ROE of 631.1% is the standout figure. An ROE in the hundreds of percent is far above what operating returns alone could generate and usually reflects a relatively small equity base combined with meaningful balance-sheet leverage. That does not erase the brand moat, but it is a reminder that Colgate-Palmolive’s competitive position is amplified by capital-structure efficiency, not just pricing power. The company’s beta of 0.33 confirms the defensive nature of the underlying cash flows, with the stock historically moving less than one-third as much as the broader market.

Financial posture

Colgate-Palmolive carries a market capitalization of $72.4 billion and trades at a trailing P/E of 35.6. Those two numbers together describe a large-cap consumer staples company valued at a clear premium to the broader market and to many of its peers. A P/E above 35 is high for a business with a 9.7% net margin; the valuation is therefore pricing in stability, durable free cash flow and low earnings volatility rather than rapid growth.

The disconnect between a modest net margin and a sky-high ROE is important. ROE measures net income relative to shareholder equity, and a figure of 631.1% implies that equity is a small slice of total capital. That can happen when a company returns significant cash to shareholders, carries debt, or both. It is not a sign of operational overperformance in isolation, but it does show that management has engineered the balance sheet to magnify returns on the equity that remains.

Technically, the stock closed at $90.52, slightly below the 50-day EMA of $91.43, with an RSI of 44.3. That RSI reading sits in neutral territory—not oversold and not overbought—and the price near its moving average suggests a market that is not strongly trending in either direction in the short term.

Strategic priorities & outlook

According to Colgate-Palmolive’s most recent 10-K filing, the company’s near-term operational priorities center on driving organic sales growth and delivering consistent, compounded earnings-per-share growth. Management is also focused on achieving operational efficiencies, growing free cash flow and using the balance sheet efficiently.

On the commercial side, Colgate-Palmolive plans to leverage its global brand reach, science-based innovation, an agile supply chain and best-in-class omni-channel demand generation. It is also investing in data, analytics and artificial intelligence while working to evolve what it describes as a high-impact, inclusive culture. These priorities line up with a scaled staples strategy: protect market share in toothpaste and home care, grow the higher-margin Hill’s Pet Nutrition franchise, and use data and AI to improve promotions, pricing and supply-chain planning.

Operationally, the company had approximately 33,600 employees as of December 31, 2025, with more than 84% located outside the United States. Walmart and its affiliates represented approximately 11% of 2025 net sales; no other customer exceeded 10%. That customer concentration is modest for a consumer-products giant and underscores the breadth of the retail network.

Macro & geopolitical exposure

As a Household & Personal Products company with global operations, Colgate-Palmolive is exposed to several macro themes. First, input-cost volatility matters. Soaps, detergents, deodorants and pet foods all rely on commodities such as palm oil, resins, pulp-based packaging, fragrances, surfactants and animal-protein inputs. When those costs rise, margins compress unless pricing keeps pace.

Second, currency risk is material. With sales in over 200 countries and more than four-fifths of employees outside the U.S., a stronger dollar reduces the translated value of overseas earnings, while a weaker dollar boosts them. That sensitivity is standard for multinational consumer staples.

Third, the industry faces ongoing regulatory and trade-policy exposure. Household and personal-care products are subject to rules on ingredient safety, labeling, advertising and environmental impact, while pet food is regulated as animal nutrition. Trade tariffs or supply-chain restrictions on raw materials can affect both cost structures and sourcing flexibility. Finally, staples companies face private-label competition during periods of consumer stress; demand itself is defensive, but brand loyalty and pricing power are tested when shoppers trade down.

Recent developments

Recent headlines have framed Colgate-Palmolive as a defensive quality name in an uncertain staples environment. On August 14, 2026, 247wallst.com included the stock among “5 Dividend Kings to Buy and Hold Forever in August.” On August 12, 2026, Zacks.com published three separate stories: “BJ or CL: Which Is the Better Value Stock Right Now?,” “4 Consumer Staples Stocks to Watch Amid Ongoing Industry Pressures,” and “Here’s Why Colgate-Palmolive (CL) is a Strong Momentum Stock.”

These articles highlight the tension investors are weighing: the company is being discussed simultaneously as a long-term dividend compounder, a value candidate and a momentum play. That mix suggests the stock is on traders’ radar less because of a dramatic operational catalyst and more because of the broader search for stability in consumer staples during industry pressures.

Earnings behavior & post-earnings drift

Colgate-Palmolive has delivered an unusually reliable earnings track record. Over the last eight reported quarters, it beat consensus estimates 8 out of 8 times, or 100%, with an average earnings surprise of 3.3%. The average price move over the five trading days following those reports has been +2.32%, classified as an “up” post-earnings drift.

The most recent quarter, reported on July 31, 2026, saw EPS of $0.99 versus an estimate of $0.947, a 4.5% beat. The stock fell 1.56% the next session but then drifted up 2.16% over the following five days. The May 1, 2026 quarter produced a 2.9% beat ($0.97 vs. $0.943), followed by a 2.17% next-day drop and a 0.33% five-day drift. The January 30, 2026 quarter generated a 4.2% beat ($0.95 vs. $0.912), with a 1.77% next-day gain and a stronger 4.56% five-day follow-through. The October 31, 2025 quarter posted a 2.4% beat ($0.91 vs. $0.889), a 2.69% next-day decline and a 2.22% five-day recovery.

The pattern is worth noting: even when the immediate next-day reaction is negative, the median or average five-day drift has tended to resolve higher. That dynamic can be useful for thinking about how expectations reset after a report, but it is not a trading signal. The company is next scheduled to report on October 30, 2026, before the market open, with the current consensus EPS estimate at $0.92.

For a deeper dive into how institutional analysts are currently rating Colgate-Palmolive, revising estimates and positioning around the upcoming October 30, 2026 earnings report, readers can explore the full institutional verdict on the stock.